Form 8-K - Current report:
SEC Accession No. 0001104659-25-053285
Filing Date
2025-05-28
Accepted
2025-05-28 07:00:43
Documents
17
Period of Report
2025-05-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2515903d2_8k.htm   iXBRL 8-K 31567
2 EXHIBIT 99.1 tm2515903d2_ex99-1.htm EX-99.1 448847
3 EXHIBIT 99.2 tm2515903d2_ex99-2.htm EX-99.2 195852
4 EXHIBIT 99.3 tm2515903d2_ex99-3.htm EX-99.3 211066
5 EXHIBIT 99.4 tm2515903d2_ex99-4.htm EX-99.4 160009
6 EXHIBIT 99.5 tm2515903d2_ex99-5.htm EX-99.5 297589
  Complete submission text file 0001104659-25-053285.txt   1690088

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rsls-20250528.xsd EX-101.SCH 3047
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rsls-20250528_lab.xml EX-101.LAB 34239
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rsls-20250528_pre.xml EX-101.PRE 22380
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2515903d2_8k_htm.xml XML 3572
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 25991124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)